National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 12 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in MaliCompletedNCT01322581
• H5N1 Mix and Match With AS03CompletedNCT01317758Phase 1
• H5N1 Mix and Match With MF59CompletedNCT01317745Phase 1
• Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)No longer availableNCT01309022
• Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary TuberculosisCompletedNCT01301144
• Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant RecipientsCompletedNCT01289717
• Praziquantel-Pharmacokinetic StudyCompletedNCT01288872Phase 1
• Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected AdultsCompletedNCT01266616Phase 1
• Malaria Surveillance in Rakai, UgandaCompletedNCT01265407
• Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S.CompletedNCT01262079
• Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected AdultsCompletedNCT01260727Phase 1
• Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus VaccineCompletedNCT01255410Phase 1
• Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and ChildrenCompletedNCT01254175Phase 1
• Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaCompletedNCT01240603
• Multiplex Microarray Chip-Based Diagnosis of Respiratory InfectionsTerminatedNCT01212042
• Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal DisordersTerminatedNCT01212016
• Assessment of Alterations in Immune Function During Pregnancy and Post ParturitionCompletedNCT01200979
• Collection of Blood, Bone Marrow, Leukapheresis, and Tissue Biopsy Samples From Patients and Their Family Members for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases Laboratory Research StudiesTerminatedNCT01200823
• A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part IIWithdrawnNCT01183455Phase 2
• Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 InfluenzaCompletedNCT01175122Phase 1
• Influenza Antiviral DAS181-F03CompletedNCT01173224Phase 1
• EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum MalariaCompletedNCT01169077Phase 1
• Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected AdultsCompletedNCT01165359Phase 1
• Comparison of Flu Vaccine Doses in ChildrenCompletedNCT01164553Phase 1
• Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 AdjuvantTerminatedNCT01164514Phase 1
• Natural History of Severe Allergic Inflammation and ReactionsCompletedNCT01164241
• A Semi-Factorial Cluster-Randomized Trial to Estimate the Effect Size of Community Mobilization and VCT Vans on the Adoption of Voluntary Counseling and Testing (VCT) Services in Andhra Pradesh, India: THE MCVCT STUDYWithdrawnNCT01160575
• Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria ImmunityCompletedNCT01160562
• Antigenic Competition in HIV Preventive VaccinesCompletedNCT01159990Phase 1
• Live Kidney Donor Study -Renal Function StudyCompletedNCT01158742
• Phase II Tularemia Vaccine ComparisonCompletedNCT01150695Phase 2
• Phase I Study of ETEC VaccineCompletedNCT01147445Phase 1
• Searching for Persistence of Infection in Lyme DiseaseCompletedNCT01143558Early Phase 1
• Safety of a Live Attenuated Human Parainfluenza Virus Type 2 (HPIV2) Vaccine for Adults, Children, and InfantsCompletedNCT01139437Phase 1
• ZOSTAVAX® in Renal Transplant PatientsCompletedNCT01137669Phase 1
• Tenofovir Gel in Pregnancy and LactationCompletedNCT01136759Phase 1
• Blood and Plasma Collection For Use in Future Clinical TrialsCompletedNCT01136057
• Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIVCompletedNCT01125228
• Collection of Peripheral Blood Stem Cells Using G-CSF and Plerixafor in Normal VolunteersTerminatedNCT01123499
• A Pilot Study Using Anakinra/Kineret for the Treatment of Patients With Severe Atopic DermatitisTerminatedNCT01122914Phase 1
• Study of Pre-clearance of Latent Tuberculosis Infection And BCG RevaccinationCompletedNCT01119521Phase 1
• Tetravalent Chimeric Dengue Vaccine TrialCompletedNCT01110551Phase 1
• Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in UgandaCompletedNCT01109342
• Safety Study of a Human Metapneumovirus Challenge Virus in Healthy AdultsCompletedNCT01109329Phase 1
• Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected AdultsCompletedNCT01103687Phase 1
• Evaluating Heterologous-Insert Prime-Boost HIV Vaccine Regimens in HIV-Uninfected AdultsCompletedNCT01095224Phase 1
• Cardiovascular Radiologic and Metabolic Assessment in HIV: An Investigation of PathophysiologyCompletedNCT01089114
• An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...CompletedNCT01086657Phase 1
• Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 VaccinesCompletedNCT01086566Phase 1
• Evaluation of the Safety and Immune Response to an Investigational Dengue Type 1 VaccineCompletedNCT01084291Phase 1
• Safety and Immune Response to an Investigational Dengue Type 2 VaccineCompletedNCT01073306Phase 1
• Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus VaccineCompletedNCT01072786Phase 1
• Tuberculosis in ChinaCompletedNCT01071603
• Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and BreastfeedingCompletedNCT01066858
• Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With InfluenzaWithdrawnNCT01063933Phase 1/2
• Non-Invasive Assessment of Atherosclerosis in Patients With CGD and Other Disorders of the Immune SystemCompletedNCT01063309
• Examining the Role of Genetics in Determining the Immune Response to an HIV Vaccine in HIV-Uninfected Adult TwinsCompletedNCT01054872Phase 1
• B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft FailureNo longer availableNCT01049633
• Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection StatusCompletedNCT01040091Phase 1
• Safety and Efficacy of Oseltamivir in Children Younger Than One Year of AgeWithdrawnNCT01037634Phase 2
• Immunogenicity of Off-Schedule Dosing of HPV VaccineCompletedNCT01030562
• EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune AdultsCompletedNCT01026246Phase 1
• Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and ChildrenCompletedNCT01021397Phase 1
• Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina FasoCompletedNCT01018459Phase 1
• Evaluating an Ebola and a Marburg Vaccine in UgandaCompletedNCT00997607Phase 1
• VRC 309: A Multi-Center, Open-Label, Randomized Phase I Study of an Investigational Influenza DNA Vaccine Followed by 2009/2010 Seasonal Influenza Trivalent Inactivated Vaccine (TIV) Compared to Two Injections of TIV in Adults 45-70 YearsCompletedNCT00995982Phase 1
• Safety, Tolerability, and Effect of TMC207 and Efavirenz in Healthy VolunteersCompletedNCT00992069Phase 1
• Safety of and Immune Response to the PENNVAX-B DNA Vaccine With and Without IL-12 in HIV-uninfected AdultsCompletedNCT00991354Phase 1
• A Pilot Study for Collection of Anti-Influenza A Immune PlasmaCompletedNCT00984451
• Phase I STEBVax in Healthy AdultsCompletedNCT00974935Phase 1
• VRC 308: An Open-Label Phase I Study of the Safety and Immunogenicity of an Investigational H1 DNA Influenza Vaccine, VRC-FLUDNA057-00-VP, in Healthy Adults 18-70 Years OldCompletedNCT00973895Phase 1
• A Phase I Study of Mozobil in the Treatment of Patients With WHIMSCompletedNCT00967785Phase 1/2
• CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly PopulationsWithdrawnNCT00964951Phase 2
• Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected IndividualsCompletedNCT00955006Phase 1
• Live Kidney Donor Study - Cross-Sectional and Historical Cohort StudyCompletedNCT00951977
• Immune Development in Pediatric Transplantation (IMPACT)CompletedNCT00951353
• Studies in the Pathogenesis of Systemic Capillary Leak SyndromeCompletedNCT00936325
• Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7CompletedNCT00922259Phase 1
• Immune Response to Varicella-Zoster Vaccination and InfectionCompletedNCT00921999
• Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy AdultsCompletedNCT00921726Phase 1
• Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue VaccineCompletedNCT00920517Phase 1
• Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue VirusCompletedNCT00919178Phase 1
• Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59CompletedNCT00912496Phase 1
• Host Factors in Invasive and Recurrent Staphylococcus Aureus InfectionTerminatedNCT00911430
• Early Immune Responses to Vaccination - A Substudy to HVTN 205CompletedNCT00908323
• Nontypeable H. Influenzae in Healthy AdultsCompletedNCT00905385Phase 1/2
• Viral Triggers in Pediatric Lung TransplantationCompletedNCT00891865
• Phase I Study of the Safety and Immunogenicity of BSAM-2/Alhydrogel +CPG 7909, an Asexual Blood Stage Vaccine for Plasmodium Falciparum Malaria in Adults in the US and MaliCompletedNCT00889616Phase 1
• Pathogenesis of Physical Induced Urticarial SyndromesCompletedNCT00887939
• Dose Escalation Study of SQ109 in Healthy Adult VolunteersCompletedNCT00866190Phase 1
• Estivation of Malaria Vector Mosquitoes in the Sahelian Region of MaliCompletedNCT00863408
• SCOT Scleroderma Treatment Alternative Registry (STAR Registry)CompletedNCT00860548
• VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...CompletedNCT00858611Phase 1
• Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy AdultsCompletedNCT00853255Phase 1
• Screening Protocol for Genetic Diseases of Allergic InflammationCompletedNCT00852943
• Intensive Viral Dynamics Substudy of A5248CompletedNCT00852618
• Safety of Acidform Lubricant in HIV-Uninfected WomenCompletedNCT00850837Phase 1
• Longitudinal Study of the Human Intestinal MicrobiomeCompletedNCT00832286Phase 1
• Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31-7164) in Healthy AdultsCompletedNCT00831012Phase 1
• The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)CompletedNCT00822276

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas